Reach Us +44-1235-425476
Editor - Ramesh Natarajan | Virginia Common wealth University | 1202
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Ramesh Natarajan

Ramesh Natarajan Ramesh Natarajan
Division of Pulmonary Disease and Critical Care Medicine
Department of Internal Medicine
Virginia Commonwealth University
Tel. 804-827-1013
Fax 804-628-0325

Dr. Natarajan is the author of more than 80 original peer reviewed research articles as well as review articles, podcasts and book chapters. He has received numerous research awards from multiple agencies including NIH. Dr. Natarajan’s research achievements in inflammation and cardiac ischemia-reperfusion have concentrated on the molecular regulation of cellular processes. Following his promotion to Assistant Professor in the VCU PCCM Division, Dr. Natarajan reported a novel pathway whereby stabilization of the HIF-1 dimer via prolyl hydroxylase inhibition (using novel small interfering RNA technology or a chemical agent) ameliorates post-ischemic myocardial injury. Following his promotion to Associate Professor in the VCU PCCM Division, Dr. Natarajan pursued his interest in sepsis and acute lung injury. Dr. Natarajan's ground breaking work with parenteral administration of ascorbic acid (vitamin C) for treatment of sepsis has been translated from the bench to the bedside with a Phase I Clinical Trial. This trial showed that parenteral administration of ascorbic acid had no adverse effects and elicited a reduction in multiple organ damage as well as mortality in patients with severe sepsis. A multi-center Phase II trial examining this treatment regimen is currently underway. Dr. Natarajan has also published extensively on the molecular regulation of right ventricular failure following pulmonary arterial hypertension (PAH).

Research Interest

His research interests include Sepsis, trauma, acute lung injury, ischemia-reperfusion, inflammation, pulmonary hypertension, emphysema, gene regulation.


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version